Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

St. Denis J. Villere & Company Ups EPIQ Systems Stake to 15.1%

St. Denis J. Villere & Company, EPIQ Systems: A few minutes ago, the New Orleans-based St. Denis J. Villere disclosed a 15.1% position in EPIQ Systems, Inc. (NASDAQ:EPIQ), a IT services company. This is an increase of about 350,000 shares since its last 13F filing, and the position’s size is easily larger than the more widely known bulls in this name, like David Dreman or Glenn Russell Dubin.

EPIQ Systems, Inc. (NASDAQ:EPIQ)

Last month, Epiq Systems declared a cash dividend that has been approved by its board of directors. Shareholders should receive $0.09 per share starting December 9, 2013. In 2012, the Board approved a share repurchase program worth $35 million, until December 31, 2013. By June, around $31.7 million remained outstanding under the buyback program. The operating revenue of Epiq increased by 64% on the year, to $70.1 million in the second quarter of 2013.

Mark Travis’s Intrepid Capital Management disclosed ownership of some 2.2 million shares of Epiq Systems, followed by Claus Moller’s P2 Capital Partners and David Dreman’s Dreman Value Management, which hold around 1.63 million shares and 256,500 shares respectively.

Disclosure: none

Recommended Reading:

Broadfin Capital Opens a Stake in Celsus, Another Biotech Company Today

CommonWealth REIT Drama Might End Next Week, Hedge Funds Paying Attention

Columbia Wanger Asset Management Loves Boingo Wireless, Closes Out on This Trio


Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!